To evaluate the clinical, radiological, and microbiological characteristics of pediatric patients with lung abscess and describe management strategies and treatment outcomes over a 13-year period (2012-2025).
Key Findings:
Lung abscesses are categorized into primary and secondary based on underlying health conditions.
Common causative agents include Staphylococcus aureus, Group A Streptococcus, Escherichia coli, and Klebsiella pneumonia.
90% of lung abscesses resolve with systemic antibiotic treatment.
Initial treatment should target Streptococcus pneumoniae and Staphylococcus aureus.
Prognosis improves with appropriate antibiotic treatment, reducing mortality to below 5%.
Distinguishing between primary and secondary lung abscesses is crucial for effective management.
Interpretation:
The study highlights the importance of distinguishing between primary and secondary lung abscesses for effective management and treatment outcomes in pediatric patients.
Limitations:
Most evidence on pediatric lung abscesses is derived from small case series or mixed populations, which may limit generalizability.
Limited comprehensive data specifically addressing pediatric cases may hinder early recognition and clinical decision-making.
Conclusion:
The findings underscore the need for pediatric-focused data to improve early recognition and management of lung abscesses in children, ultimately enhancing treatment outcomes.
